Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid  by Smith, Jeffrey J et al.
Cell, Vol. 85, 229±236, April 19, 1996, Copyright 1996 by Cell Press
Cystic Fibrosis Airway Epithelia
Fail to Kill Bacteria
Because of Abnormal Airway Surface Fluid
Jeffrey J. Smith,* Sue M. Travis,² E. Peter Greenberg,³ characteristic physiologic abnormality, defective trans-
epithelial Cl2 transport.and Michael J. Welsh²§‖
In other organs affected by CF, disease pathogenesis*Department of Pediatrics
does not involve bacterial infections. For the sweat²Department of Internal Medicine
gland, pancreas, intestine, and male genital tract,plausi-³Department of Microbiology
ble explanations of pathogenesis arebased on defective§Department of Physiology and Biophysics
transepithelial Cl2 transport (Quinton, 1990; Welsh et‖Howard Hughes Medical Institute
al., 1995). Likewise, as suggested by Quinton (1984)University of Iowa College of Medicine
over a decade ago, defective transepithelial electrolyteIowa City, Iowa 52242
transport might somehow be responsible for the patho-
genesis of airway infections. In airway epithelia, the loss
of CFTR Cl2 channel function, perhaps combined with
Summary a secondary defect in Na1 transport, leads to abnormal
transepithelial salt and fluid transport (Boucher et al.,
Despite an increased understanding of the cellular and 1983; Jiang et al., 1993; Smith and Welsh, 1993; Smith
molecular biology of the CFTR Cl2 channel, it is not et al., 1994). As a result, the composition of airway sur-
known how defective Cl2 transport across airway epi- face fluid is abnormal. Joris et al. (1993) and Gilljam et
thelia causes chronic bacterial infections in cystic fi- al. (1989) have shown that airway surface fluid from
brosis (CF) airways. Here, we show that common CF patients with CF has increased concentrations of Cl2
pathogens were killed when added to the apical sur- and Na1 when compared with that of normal subjects.
face of normal airway epithelia. In contrast, these bac- But how do these abnormalities relate to airway infec-
teria multiplied on CF epithelia. We found that bacteri- tions?
cidal activity was present in airway surface fluid of
both normal and CF epithelia. However, because bac-
terial killing required a low NaCl concentration and Results
because CF surface fluid has a high NaCl concentra-
tion, CF epithelia failed to kill bacteria. This defect was Normal but Not CF Epithelia Kill Bacteria
corrected by reducing the NaCl concentration on CF Applied to the Apical Surface
epithelia. These data explain how the loss of CFTR Cl2 Human airways are continually exposed to bacteria in
channels may lead to lung disease and suggest new ambient air (103/m3) and to aspirated bacteria (DeKoster
approaches to therapy. and Thorne, 1995; Huxley et al., 1978). Despite this expo-
sure, the intrapulmonary airways remain sterile in
healthy individuals. To begin our study of airway de-
Introduction fenses, we asked what happens when bacteria are
placed on normal airway epithelia. We used primary
The past few years have brought dramatic advances in cultures of human airway epithelial cells as the model
our knowledge of the molecular and cellular basis of CF for these experiments. This model eliminates the anti-
(for reviews see Collins, 1992; Riordan, 1993; Welsh et bacterial contribution of immune and inflammatory cells.
al., 1995). We now know that the disease is caused We cultured the cells on permeable filter supports with
by mutations in the gene encoding the cystic fibrosis air on the apical surface. Under these conditions, the
transmembrane conductance regulator (CFTR), a phos- cells form a continuous, polarized sheet that develops
phorylation-regulated Cl2 channel located in the apical a transepithelial electrical resistance and that actively
membrane of involved epithelia. As well, much has been transports Na1 and Cl2 across the epithelium (Yamaya
discovered about how CF-associated mutations disrupt et al., 1992). Moreover, primary cultures of CF epithelia
protein function, thereby disrupting Cl2 transport across grown in this way manifest theCF defect inCl2 transport.
CF epithelia. Figure 1 shows that, under these conditions, epithelia
Despite these advances, we do not understand the develop a ciliated apical surface resembling that ob-
pathogenesis of CF lung disease, the major cause of served in vivo (Breeze and Wheeldon, 1977).
morbidity and mortality. Lung disease is characterized To mimic further the situation in vivo, we inoculated
by bacterial colonization and chronic airway infection. bacteria directly onto the air-covered apical surface of
Many organisms can be involved, but Pseudomonas normal airway epithelia, using a small volume (20 nl).
aeruginosa and Staphylococcus aureus are particularly We added30±300 colony-forming units (cfu)of P. aerugi-
prominent (Konstan and Berger, 1993). Chronic bacterial nosa to the surface and then placed the epithelia in a
infections progressively destroy the lung and may ulti- humidified cell culture incubator at 378C. Within 24 hr
mately lead to respiratory failure. Several hypotheses after the bacteria were added to the apical surface, we
have been proposed to explain the pathogenesis of CF recovered either no P. aeruginosa or fewer than we had
lung disease (Davis, 1993; Wine, 1995; Pilewski and Friz- added (Figure 2A). Moreover, the epithelia remained via-
zell, 1995; Welsh et al., 1995). However, it has been ble and uninfected for as long as they were maintained
difficult to relate the characteristic disease abnormality, afterward (up to 3 weeks). We obtained strikingly differ-
ent results with CF airway epithelia (Figure 2A); 24 hrbacterial colonization and infection of airways, to the
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Figure 1. Scanning Electron Photomicro-
graphs of the Apical Surface of Cultured Nor-
mal Airway Epithelium Studied 41 Days After
Seeding
Top panel is low magnification. Bottom panel
shows an area of epithelium with a thin layer
of material covering the apical surface. The
bar indicates 3 mm.
after adding P. aeruginosa to the apical surface, we The airways of CF patients are colonized by many
recovered more bacteria than had been added. When different bacteria; S. aureus is often one of the first
we expressed CFTR in CF epithelia using a recombinant organisms detected (Ramsey et al., 1991; Konstan and
adenovirus, the defect in killing P. aeruginosa was cor- Berger, 1993). Figure 2D shows that normal epithelia
rected (Figure 2A). Treatment with a related adenovirus also killed a methicillin-resistant clinical isolate of S.
vector expressing b-galactosidase had no effect. These aureus added to the apical surface. Again, in contrast
data indicate that airway epithelia possess an anti-Pseu- with normalepithelia, S. aureus multiplied on thesurface
domonas activity that is dependent on CFTR. of CF epithelia.
Figure 2B shows that when we added up to 103 P.
aeruginosa to normal epithelia, there were always fewer
Normal and CF Airway Surface Fluidsbacteria present 24 hr later. However, when we added
Contain Bactericidal Activitymore than 103 P. aeruginosa, a greater number of bacte-
Because bacteria were killed after addition to the smallria were recovered 24 hr later, suggesting that the anti-
amount of fluid covering the apical surface of normalbacterial system was overwhelmed. Yet when even a
epithelia,we asked whether there was bactericidal activ-small number of bacteria were added to the basolateral
ity in this airway surface fluid. We collected airway sur-solution, there was always profuse growth (Figure 2B),
face fluid by washing the apical surface with water andsuggesting that the antibacterial activity was localized
then added P. aeruginosa to the recovered fluid. Fluidto the apical surface of the epithelia. The rate of killing
recovered from normal airway surfaces killed P. aerugi-is shown in Figure 2C; 3 hr afteraddition of P. aeruginosa
nosa (Figure 3A). Conversely, immediately after washingto the apical surface, the number of viable bacteria had
the apical surface, epithelia lost the ability to kill P.decreased by about 50%. In contrast to airway epithelia,
aeruginosa (Figure 3B). Airway surface fluid also killedwhen we added less than 100 cfu of P. aeruginosa to
Escherichia coli and clinical isolates of P. aeruginosathe apical surface of Fisher rat thyroid epithelia, there
was abundant growth (n 5 15; data not shown). and methicillin-resistant S. aureus (Figure 3A). These
Defective Bacterial Killing by CF Airway Epithelia
231
Figure 2. Killing of Bacteria by Airway Epi-
thelia
(A) P. aeruginosa recovered from normal and
CF epithelia 24 hr after additionof 30±300 cfu.
CF epithelia were treated with Ad2±CFTR-8
or Ad2±b-gal-2, as indicated, 3±4 days before
addition of P. aeruginosa. Each data point is
from an individual epithelium. Asterisk indi-
cates p < 0.0001 compared with normal epi-
thelia; double asterisk indicates p < 0.003
compared with CF epithelia without Ad2±
CFTR-8.
(B) P. aeruginosa recovered after addition of
indicated number of bacteria to the apical
surface (closed triangles) or basolateral solu-
tion (open circles). Data points indicate the
total cfu recovered from each epithelium.
(C) Effect of duration of incubation onP. aeru-
ginosa recovered after addition of 137 6 30
cfu to the apical surface of normal airway
epithelia. Data are mean 6 standard error of
the mean; n 5 3 epithelia at each timepoint.
(D) S. aureus recovered 24 hr after addition
of 70 6 8 cfu to the apical surface of normal
or CF epithelia. Asterisk indicates p < 0.02.
results suggest that airway surface fluid contains broad- and heat stability are characteristic of defensins (Lehrer
et al., 1993; Martin et al., 1995).spectrum bactericidal activity.
The broad spectrum of bactericidal activity suggested Because bacteria multiplied on the surface of CF epi-
thelia, we asked whether the bactericidal factor wasthat surface fluid might contain a defensin-like factor
(Lehrer et al., 1993; Martin et al., 1995). Microfiltration missing in CF. Interestingly, airway surface fluid col-
lected in water from either normal or CF epithelia killedexperiments indicated that the bactericidal factor ap-
peared to be smaller than 10 kDa; airway surface fluid P. aeruginosa (Figure 3C). This finding indicates that CF
epithelia do not lack a bactericidal factor. Therefore, wethat had passed through a Microcon-10 filter (Amicon)
had anti-Pseudomonas activity equal to that of unfil- hypothesized that CF epithelia fail to kill P. aeruginosa
(see Figure 2A) because the composition of airway sur-tered airway surface fluid (n 5 12). In addition, boiling
the fluid for 10 min did not abolish its activity as com- face fluid is altered so as to inhibit the activity of a
bactericidal factor.pared with unboiled fluid (n 5 12). A low molecular mass
Figure 3. Killing of Bacteria by Airway Surface Fluid
(A) Bacteria recovered after incubation in airway surface fluid (ASF) collected in water from normal epithelia. P. aeruginosa (PAO1S) (49 6 9
cfu), a clinical isolate of P. aeruginosa (69 6 19 cfu), a clinical isolate of S. aureus (58 6 9 cfu), or E. coli HB101 (351 6 115 cfu) were incubated
in water (control) or airway surface fluid in water (ASF) at 378C for 3 hr. Data are mean 6 standard error of the mean; n 5 3 for each point.
Asterisk indicates p < 0.006 compared with control.
(B) P. aeruginosa recovered 24 hr after addition to normal epithelia, as described in legend to Figure 2, or to epithelia in which the apical
surface had been washed before addition of bacteria. Asterisk indicates p < 0.01.
(C) P. aeruginosa (665 6 75 cfu) was added to water alone (control) or to airway surface fluid collected in water from CF or normal airway
epithelia and incubated at 378C for 3 hr. Similar results were obtained in three other sets of experiments in which 25±70 cfu were added.
Asterisk indicates p < 0.001 compared with control.
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5C). These data indicate that although the electrolyte
composition affects bactericidal activity, it does not af-
fect the ability to recover the bactericidal factor from
the airway surface.
Reduction of the NaCl Concentration Allows
CF Epithelia to Kill P. aeruginosa
These results suggest that CF epithelia produce a bacte-
ricidal factor that fails to kill bacteria applied to their
apical surface because the surface fluid has an abnor-
mally high salt concentration. Thus, we reasoned that
if we altered the electrolyte concentration on the airway
surface, we would alter bactericidal activity. To test this
hypothesis, we applied a small amount of solution (60
ml) with a known salt concentration to the apical surfaceFigure 4. Concentration of Cl2 in Airway Surface Fluid Collected
from Nasal Epithelium of CF and Normal Subjects of normal and CF airway epithelia and then added P.
CF, n 5 8; normal, n 5 17. Each point is the value from an individual aeruginosa. When P. aeruginosa was added to normal
subject; mean 6 standard error of the mean are indicated. Asterisk epithelia covered with a solution containing a low Cl2
indicates p < 0.001 compared with normal. concentration, the bacteria were killed (Figure 6A). This
result is the same with direct addition of P. aeruginosa
to the airway surface (see Figure 2A). However, with aAirway Surface Fluid from CF Epithelia Has an
high salt concentration on the apical surface of normalAbnormally Increased Cl2 Concentration
epithelia, the bacteria multiplied. Thus, increasing theJoris et al. (1993) and Gilljam et al. (1989) used bronchos-
salt concentration caused normal epithelia to behavecopy to obtain airway surface fluid from the trachea and
like CF epithelia. Most importantly, when the salt con-main stem bronchi of normal and CF subjects. They
centration was reduced, bacteria placed on CF epitheliafound that normal fluid had Cl2 concentrations of 84 6
were killed (Figure 6B). Thus, a low salt concentration9 mM and 85 6 54 mM, respectively, whereas CF fluid
allowed CF epithelia to kill P. aeruginosa.had higher Cl2 concentrations of 129 6 5 mM and
Scanning electron photomicrographs confirmed170 6 79 mM, respectively. To confirm this difference,
these results. We added P. aeruginosa to CF epitheliawe measured the Cl2 concentration in airway surface
covered with a thin layer of solution containingeither 182fluid obtained from the nasal mucosa; we used nasal
mM Cl2 or 92 mM Cl2. Within 48 hr after their addition tomucosa because the function and histology of the epi-
epithelia with a high salt concentration, we observed P.thelium is similar to that of intrapulmonary airways, and
aeruginosa on the apical surface (Figure 7A). In contrast,it is easily accessible. Like the earlier reports, our data
we could not find bacteria on CF epithelia when the saltshowed that the Cl2 concentration in CF fluid (182 6 10
concentration was low (Figure 7B).mM) was higher than in normal fluid (132 6 3 mM) (Figure
4). Evaporation or methodological differences or both
may account for the fact that we found higher Cl2 con- Discussion
centrations in nasal fluid than were reported in tracheal
fluid (Joris et al., 1993; Gilljam et al., 1989). However, These data provide a link between the physiologic hall-
mark of CF, defective transepithelial Cl2 transport, andthe important point is that Cl2 concentrations were sig-
nificantly higher in CF. This may occur because the loss the clinical hallmark of CF, airway infections with CF
pathogens such as P. aeruginosa and S. aureus. Theof CFTR Cl2 channels prevents Cl2 from accompanying
Na1 absorption, much as occurs in CF sweat ducts results suggest that airway epithelia secrete a bacteri-
cidal substance into the thin layer of fluid covering the(Quinton, 1990, 1994).
apical surface, where its activity depends on a low salt
concentration. In CF epithelia, loss of CFTR Cl2 channelsAn Increased NaCl Concentration Inhibits
Bactericidal Activity in Airway Surface Fluid produces an abnormally high salt concentration in the
airway surface fluid, which reduces bactericidal activity.To learn whether the electrolyte concentration could
affect bactericidal activity, we removed airway surface When the salt concentration is lowered, CF epithelia can
kill P. aeruginosa.fluid with solutions containing different concentrations
of NaCl and tested the ability of the fluid to kill bacteria Bactericidal activity in the airway surface fluid may
be the first line of defense that protects the lung fromin vitro. As the concentration of NaCl increased, anti-
Pseudomonas activity decreased (Figure 5A). Similar bacteria and helps maintain a sterile intrapulmonary en-
vironment. Loss of this activity could explain lung dis-results were obtained with clinical isolates of P. aerugi-
nosa and S. aureus and with E. coli (Figures 5A and 5B). ease in patients with CF as follows. Bacteria deposit
on the airway surface after inhalation and aspiration.These data indicate that increased electrolyte concen-
trations reduce bactericidal activity. Normally, they would be killed by bactericidal activity
in airway surface fluid. However, our data suggest thatBactericidal activity was also present when we col-
lected airway surface fluid with 140 mM NaCl (instead this system is impaired in CF. As a result, a second line
of defense, neutrophils and macrophages, may kill theof with water) and then diluted the fluid toa NaClconcen-
tration of 47 mM before adding P. aeruginosa (Figure bacteria and release cytokines that recruit additional
Defective Bacterial Killing by CF Airway Epithelia
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Figure 5. Bactericidal Activity of Airway Surface Fluid Collected in Either Water or the Indicated Concentration of NaCl
Data are means 6 standard error of the mean of the bacteria recovered (as a percent of inoculum) 3 hr after addition of the following:
(A) 49 6 9 cfu P. aeruginosa PAO1S or 38 6 4 cfu of a clinical isolate of P. aeruginosa; or (B) 58 6 9 cfu of a clinical isolate of S. aureus or
351 6 115 cfu E. coli HB101. n 5 3 for each point; in some cases, the error bars are hidden by symbols. Asterisk indicates values significantly
less than the amount added (p < 0.005).
(C) Airway surface fluid was collected by washing the apical surface of normal epithelia with 60 ml of 140 mM NaCl. This solution was then
diluted 1:2 with water (final NaCl concentration, 47 mM). Data are P. aeruginosa recovered after 3 hr incubation at 378C. Control indicates
salt solution (47 mM NaCl) containing no airway surface fluid. Asterisk indicates value different from control, p < 0.001.
neutrophils, thereby generating an inflammatory envi- chronic infection may stimulate hypertrophy of submu-
cosal glands and cause mucus hypersecretion (LariveÂ e,ronment (Wilmott et al., 1990; Davis, 1993; Konstan and
Berger, 1993; Goldstein and Shak, 1994). Evidence for 1994; Levine et al., 1995). Although many organisms
infect CF airways, P. aeruginosa and S. aureus mayinvolvement of this second line of defense is that inflam-
matory cells and cytokines have been found in the air- become particularly common as the disease progresses
ways of very young patients with CF, even before the for the following reasons: because antibiotics used to
onset of overt infection (Khan et al., 1995; Balough et treat lung infections may select for these organisms,
al., 1995). With time, the host defense mechanisms may because systems that serve as a second line of defense
be overwhelmed and the immune and inflammatory re- may have difficulty eliminating these bacteria, and be-
sponses become profuse (Davis, 1993; Konstan and Ber- cause these organisms may possess properties (such
ger, 1993). The abundant inflammatory mediators and as increased adherence to CF epithelia) that enhance
colonization (Fick et al., 1981; Saiman and Prince, 1993;
Konstan and Berger, 1993). The combination of infection
and increased amounts of mucus and inflammatory cells
could generate the viscid secretions that impair muco-
ciliary clearance as the disease advances (Regnis et al.,
1994; Yeates et al., 1976; Sanchis et al., 1973). Inflamma-
tion and infection then lead to progressive lung destruc-
tion (Davis, 1993; Welsh et al., 1995). Our data also help
explain why patients with CF are not predisposed to
infections at other sites; a local defense mechanism is
impaired only in the airways.
There have been several other recent proposals to
explain the pathogenesis of CF lung disease. It has been
suggested that impaired phagocytosis of P. aeruginosa
might be the basis of infections (Pier et al., 1996), a
conclusion based on decreased phagocytosis of P. aer-
uginosa by a transformed CF epithelial cell line grown
on tissue culture plates. However, phagocytosis of S.
aureus, another common CF pathogen, was not abnor-Figure 6. Effect of Cl2 Concentration on the Bactericidal Activity of
mal. It has also been reported that adherence of P.Normal and CF Epithelia
aeruginosa to CF airway epithelia is slightly increased,(A) shows normal and (B) shows CF epithelia. The apical surface of
possibly because the amount of asialoGM1 is increasedepithelia was coveredwith 60 ml of a solution containing 1 mM CaCl2,
20 mM KCl, and either 70 or 160 mM NaCl (total Cl2 concentration on the surface of CF cells (Saiman and Prince, 1993;
indicated for each data bin). The basolateral solution (culture media) Imundo et al., 1995). Because submucosal glands ex-
was diluted with water to minimize transepithelial osmotic gradients. press high levels of CFTR, it has been suggested that
Epithelia were incubated for 24 hr after addition of P. aeruginosa
their secretions may be abnormal in CF, leading to a(325 6 54 cfu). In separate experiments, we found that after 24 hr,
predisposition to infection (Engelhardt et al., 1992). Ourthe Cl2 concentration on the apical surface remained within 6 mM
results do not exclude a role for any of these factorsof the starting concentration. Each data point is from a separate
epithelium. Asterisk indicates p < 0.003 compared with 182 mM Cl2. in the development of chronic bacterial infection, lung
Cell
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Figure 7. Scanning Electron Photomicro-
graphs of the Surface of CF Epithelia
P. aeruginosa (PAO1S 459 6 47 cfu) was
added 48 hr before processing. Epithelia
were covered with 60 ml of a solution con-
taining either 182mM Cl2 (A) or92 mM Cl2 (B),
as described in legend to Figure 6. Bacteria
were usually found on a thin film of material
with a mucus-like appearance. Cilia are visi-
ble beneath the thin film of material. Arrow
indicates P. aeruginosa. Bar indicates 3 mm.
destruction, or both. Yet, without invoking other propos- determining the effectiveness of potential therapeutic
interventions. It will be interesting to learn how pharma-als, our data showing that electrolyte composition af-
fects bacterial survival provide an explanation for why ceuticals designed to alter electrolyte transport, such
as amiloride and UTP (Knowles et al., 1990, 1991), affectCF airways are not maintained as a sterile environment.
We speculate that the bactericidal factor produced electrolyte composition. In the case of gene therapy,
knowledge of the relationship among the percentage ofby airway epithelia may be a defensin-like molecule,
because it has several properties characteristic of such cells that express CFTR, the amount of CFTR expression
per cell, and correction of the abnormal composition offactors (for reviews see Lehrer et al., 1993; Martin et al.,
1995): it is a low molecular mass, heat-stable substance airway surface fluid may help guide therapeutic trials.
The data also raise the intriguing possibility that newthat has broad-spectrum bactericidal activity, and killing
is dependent on salt concentration. In addition, expres- interventions designed to correct the abnormally high
salt concentration in CF fluid could be of benefit in treat-sion of a defensin has been detected in bovine airway
epithelial cells (Diamond et al., 1993). Identification of ing or preventing airway infections in people with CF.
the bactericidal factor and elucidation of its mechanism
of action will provide additional insights into local pulmo- Experimental Procedures
nary defense mechanisms and could lead to the devel-
opment of more effective bactericidal agents. Culture of Epithelia
Airway epithelial cells were isolated from nasal, tracheal, and bron-Our results link themolecular defect in CFTR Cl2 chan-
chial epithelia from 5 CF and 14 normal (non-CF) people. Cells werenels to the pathogenesis of CF lung disease. More im-
seeded on collagen-coated, semipermeable membranes (0.6 cm2)portantly, the data suggest novel assays for evaluating
and grown at the air±liquid interface as previously described (Ya-
potential treatments and new approaches to therapy. maya et al., 1992). Because we were establishing primary cultures,
For example, measurements of salt concentration and for 2±4 days after seeding, the culture medium contained either 100
mU/ml penicillin plus 100 mg/ml streptomycin or the combinationbactericidal activity may be clinically relevant assays for
Defective Bacterial Killing by CF Airway Epithelia
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of penicillin, streptomycin, 50 mg/ml gentamicin, 40 mg/ml tobra- could collect bactericidal activity on several occasions over many
days from a single epithelium.mycin, 15 mg/ml colymycin, 125 mg/ml ceftazidime, and 2 mg/ml
fluconizole. Similar results were obtained with epithelia initially Evidence that epithelia were not damaged by collection of surface
fluid includes the following: after washing, epithelia retained theirtreated with either antibiotic mixture. After antibiotic treatment, the
basolateral solution was replaced five times over 48 hr with antibi- transepithelial resistance and electrolyte transport properties; there
was no leakage of fluid from the basolateral to the apical surface;otic-free medium, and the apical surface was washed three times
over 48 hr with antibiotic-free phosphate-buffered Ringer's solution. and 24 hr after washing, we could again recover bactericidal activity.
Moreover, as described above and in Figure 5C, bactericidal activityThereafter, the antibiotic-free medium was changed at 2±3 day inter-
vals. Epithelia were studied 8±45 days after seeding and showed could be recovered either with water or with a NaCl solution.
bactericidal activity even after many changes of the basolateral
solutionand many washes over time of the apicalsolution. All epithe- Collection and Analysis of Airway Surface Fluid
lia used showed no leakage of fluid from the basolateral to the apical from Normal and CF Subjects
surface, and paired monolayers had transepithelial resistances of Airway surface fluid was collected from 8 CF and 17 normal subjects.
.500 V 3 cm2. Epithelia were prepared for scanning electron mi- Before collection, subjects wore a nose clip for 5 min to prevent
croscopy using standard techniques. breathing through the nose. Immediately after removal of the nose
In some studies, epithelia were treated with recombinant adenovi- clip, a 0.32 cm2 filter (66213, Gelman Sciences, Ann Arbor, MI) was
rus to express CFTR. Previous studies have shown that Ad2±CFTR- gently applied to the inferior surface of the inferior turbinate. After
8 (moi 5 50) used under these conditions corrects the fluid and 5 s, the filter was withdrawn and immediately immersed in mineral
electrolyte transport defects in CF epithelia (Zabner et al., 1994; J. oil to prevent evaporation. The mineral oil was not water saturated.
Zabner and M. J. W., unpublished data). As a control, some epithelia Fluid was extracted from the filter as follows. The bottom of the
were exposed to Ad2±b-gal-2, which expresses b-galactosidase. microcentrifuge tube holding the filter in mineral oil was perforated,
As an additional control, one epithelium in each experiment was and the tube was placed into a larger tube containing mineral oil.
used to study the electrical properties to determine that cAMP- The tandem tubes were centrifuged at 174,000 3 g for 15 min to
stimulated Cl2 transport was corrected by treatment with Ad2± transfer the fluid into the larger tube without exposing it to air; the
CFTR-8. Fisher rat thyroid epithelia were cultured as described filter remained in the smaller microcentrifuge tube. Fluid samples
(Sheppard et al., 1994). collected from both nostrils of a subject were pooled, and Cl2 con-
centrations were measured by chloridometry (Labconco Corp., Kan-
sas City, MO). Control samples containing known Cl2 concentra-Bacterial Stains and Culture Conditions
tions were separated, stored, and analyzed in an identical manner;We used several bacteria, as follows: a laboratory strain of P. aerugi-
in the control samples, Cl2 concentrations were always within 5 mMnosa (PAO1S), a spontaneously occurring streptomycin-resistant
of the original concentration.mutant of the naturally ampicillin-resistant strain PAO1 (isolated by
Dr. C. Cox); E. coli HB101 (a streptomycin-resistant strain); a clinical
Acknowledgmentsisolate of P. aeruginosa (a mucoid strain from a CF patient); and a
methicillin-resistant clinical isolate of S. aureus. Bacteria were
Correspondence should be addressed to J. J. S. We thank Dr.grown overnight in Luria broth. They were then washed three times
Charles Cox for PAO1S, Dr. Frank Koontz for clinical isolates of P.in water, centrifuged at 4000 3 g for 15 min, and diluted in water
aeruginosa and S. aureus, Dr. Joseph Zabner for help in developingto an appropriate density. The number of cfu were also measured
and validating the model of airway epithelia, and Drs. Alan Smithdirectly in triplicate by plating 20 nl on Luria agar and counting
and Sam Wadsworth for recombinant adenoviruses. We thank Xiaojicolonies.
Zhang, Philip Karp, Pary Weber, Jan Launspach, and Tom Moninger
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